Related references
Note: Only part of the references are listed.Emergence of immunosuppressive LOX-1+PMN-MDSC in septic shock and severe COVID-19 patients with acute respiratory distress syndrome
Remy Coudereau et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2022)
Immunopathology of Hyperinflammation in COVID-19
Joshua N. Gustine et al.
AMERICAN JOURNAL OF PATHOLOGY (2021)
COVID-19 risk stratification algorithms based on sTREM-1 and IL-6 in emergency department
Mathias Van Singer et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2021)
Increased expression of hypoxia-induced factor 1α mRNA and its related genes in myeloid blood cells from critically ill COVID-19 patients
Keiko Taniguchi-Ponciano et al.
ANNALS OF MEDICINE (2021)
COVID-19 vaccines: where we stand and challenges ahead
Guido Forni et al.
CELL DEATH AND DIFFERENTIATION (2021)
Induction of alarmin S100A8/A9 mediates activation of aberrant neutrophils in the pathogenesis of COVID-19
Qirui Guo et al.
CELL HOST & MICROBE (2021)
SARS-CoV-2-Induced ARDS Associates with MDSC Expansion, Lymphocyte Dysfunction, and Arginine Shortage
Florian Reizine et al.
JOURNAL OF CLINICAL IMMUNOLOGY (2021)
Major alterations in the mononuclear phagocyte landscape associated with COVID-19 severity
Egle Kvedaraite et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2021)
Reduced Expression of Autophagy Markers and Expansion of Myeloid-Derived Suppressor Cells Correlate With Poor T Cell Response in Severe COVID-19 Patients
Sergej Tomic et al.
FRONTIERS IN IMMUNOLOGY (2021)
Enhanced expression of immune checkpoint receptors during SARS-CoV-2 viral infection
Narjes Saheb Sharif-Askari et al.
MOLECULAR THERAPY-METHODS & CLINICAL DEVELOPMENT (2021)
Functional monocytic myeloid-derived suppressor cells increase in blood but not airways and predict COVID-19 severity
Sara Falck-Jones et al.
JOURNAL OF CLINICAL INVESTIGATION (2021)
Myeloid cell dynamics correlating with clinical outcomes of severe COVID-19 in Japan
Tomohiro Takano et al.
INTERNATIONAL IMMUNOLOGY (2021)
Myeloid-derived suppressor cells in the era of increasing myeloid cell diversity
Filippo Veglia et al.
NATURE REVIEWS IMMUNOLOGY (2021)
Epigenetic therapy inhibits metastases by disrupting premetastatic niches
Zhihao Lu et al.
NATURE (2020)
Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study
Fei Zhou et al.
LANCET (2020)
Severe Covid-19
David A. Berlin et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Severe COVID-19 Is Marked by a Dysregulated Myeloid Cell Compartment
Jonas Schulte-Schrepping et al.
CELL (2020)
Elevated Calprotectin and Abnormal Myeloid Cell Subsets Discriminate Severe from Mild COVID-19
Aymeric Silvin et al.
CELL (2020)
Expansion of myeloid-derived suppressor cells in patients with severe coronavirus disease (COVID-19)
Chiara Agrati et al.
CELL DEATH AND DIFFERENTIATION (2020)
Elevated interleukin-6, interleukin-10 and neutrophil : lymphocyte ratio as identifiers of severe coronavirus disease 2019
Andrew Godkin et al.
IMMUNOLOGY (2020)
Pathophysiology, Transmission, Diagnosis, and Treatment of Coronavirus Disease 2019 (COVID-19) A Review
W. Joost Wiersinga et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2020)
Role of Monocytes/Macrophages in Covid-19 Pathogenesis: Implications for Therapy
Jose Gomez-Rial et al.
INFECTION AND DRUG RESISTANCE (2020)
Neutrophil Extracellular Traps (NETs) and Damage-Associated Molecular Patterns (DAMPs): Two Potential Targets for COVID-19 Treatment
Sebastiano Cicco et al.
MEDIATORS OF INFLAMMATION (2020)
Mapping Systemic Inflammation and Antibody Responses in Multisystem Inflammatory Syndrome in Children (MIS-C)
Conor N. Gruber et al.
CELL (2020)
Longitudinal analyses reveal immunological misfiring in severe COVID-19
Carolina Lucas et al.
NATURE (2020)
Impaired type I interferon activity and inflammatory responses in severe COVID-19 patients
Jerome Hadjadj et al.
SCIENCE (2020)
Quantitative and qualitative alterations of circulating myeloid cells and plasmacytoid DC in SARS-CoV-2 infection
Benedetta Peruzzi et al.
IMMUNOLOGY (2020)
COVID-19 and myeloid cells: complex interplay correlates with lung severity
Franco R. D'Alessio et al.
JOURNAL OF CLINICAL INVESTIGATION (2020)
A Granulocytic Signature Identifies COVID-19 and Its Severity
Joana Vitte et al.
JOURNAL OF INFECTIOUS DISEASES (2020)
Prostaglandin D2 as a mediator of lymphopenia and a therapeutic target in COVID-19 disease
Ajay Gupta et al.
MEDICAL HYPOTHESES (2020)
A dynamic COVID-19 immune signature includes associations with poor prognosis
Adam G. Laing et al.
NATURE MEDICINE (2020)
Systems biological assessment of immunity to mild versus severe COVID-19 infection in humans
Prabhu S. Arunachalam et al.
SCIENCE (2020)
Autoantibodies against type I IFNs in patients with life-threatening COVID-19
Paul Bastard et al.
SCIENCE (2020)
Targeting Neutrophils to Treat Acute Respiratory Distress Syndrome in Coronavirus Disease
Chih-Chao Chiang et al.
FRONTIERS IN PHARMACOLOGY (2020)
Re-analysis of Single Cell Transcriptome Reveals That the NR3C1-CXCL8-Neutrophil Axis Determines the Severity of COVID-19
Jang Hyun Park et al.
FRONTIERS IN IMMUNOLOGY (2020)
The differential immune responses to COVID-19 in peripheral and lung revealed by single-cell RNA sequencing
Gang Xu et al.
CELL DISCOVERY (2020)
Longitudinal immune profiling reveals key myeloid signatures associated with COVID-19
Elizabeth R. Mann et al.
SCIENCE IMMUNOLOGY (2020)
SARS-CoV-2 infection induces mixed M1/M2 phenotype in circulating monocytes and alterations in both dendritic cell and monocyte subsets
Sanja Matic et al.
PLOS ONE (2020)
Monocyte HLA-DR Measurement by Flow Cytometry in COVID-19 Patients: An Interim Review
Ihsane Benlyamani et al.
CYTOMETRY PART A (2020)
Single-Cell Transcriptome Analysis Highlights a Role for Neutrophils and Inflammatory Macrophages in the Pathogenesis of Severe COVID-19
Hibah Shaath et al.
CELLS (2020)
Early expansion of myeloid-derived suppressor cells inhibits SARS-CoV-2 specific T-cell response and may predict fatal COVID-19 outcome
Alessandra Sacchi et al.
CELL DEATH & DISEASE (2020)
Pathological inflammation in patients with COVID-19: a key role for monocytes and macrophages
Miriam Merad et al.
NATURE REVIEWS IMMUNOLOGY (2020)
COVID-19-associated hyperinflammation and escalation of patient care: a retrospective longitudinal cohort study
Jessica J. Manson et al.
LANCET RHEUMATOLOGY (2020)
Tryptophan metabolism as a common therapeutic target in cancer, neurodegeneration and beyond
Michael Platten et al.
NATURE REVIEWS DRUG DISCOVERY (2019)
Fatty acid transport protein 2 reprograms neutrophils in cancer
Filippo Veglia et al.
NATURE (2019)
Myeloid-Derived Suppressor Cells: Not Only in Tumor Immunity
Graham Pawelec et al.
FRONTIERS IN IMMUNOLOGY (2019)
Myeloid-Derived Suppressor Cells: Immune-Suppressive Cells That Impair Antitumor Immunity and Are Sculpted by Their Environment
Suzanne Ostrand-Rosenberg et al.
JOURNAL OF IMMUNOLOGY (2018)
Myeloid-Derived Suppressor Cells in Infection: A NGeneral Overview
Eva Medina et al.
JOURNAL OF INNATE IMMUNITY (2018)
Myeloid-derived suppressor cells coming of age
Filippo Veglia et al.
NATURE IMMUNOLOGY (2018)
Monocytic Myeloid-Derived Suppressor Cells in Chronic Infections
Anca Dorhoi et al.
FRONTIERS IN IMMUNOLOGY (2018)
The Role of Myeloid-Derived Suppressor Cells in Viral Infection
Megan A. O'Connor et al.
VIRAL IMMUNOLOGY (2017)
B cell regulation in cancer and anti-Xtumor immunity
Anushruti Sarvaria et al.
CELLULAR & MOLECULAR IMMUNOLOGY (2017)
Dysregulated Type I Interferon and Inflammatory Monocyte-Macrophage Responses Cause Lethal Pneumonia in SARS-CoV-Infected Mice
Rudragouda Channappanavar et al.
CELL HOST & MICROBE (2016)
Recommendations for myeloid-derived suppressor cell nomenclature and characterization standards
Vincenzo Bronte et al.
NATURE COMMUNICATIONS (2016)
Myeloid-Derived Suppressor Cells in Bacterial Infections
Michael Ost et al.
FRONTIERS IN CELLULAR AND INFECTION MICROBIOLOGY (2016)
Metabolic regulation of hepatitis B immunopathology by myeloid-derived suppressor cells
Laura J. Pallett et al.
NATURE MEDICINE (2015)
Id1 suppresses anti-tumour immune responses and promotes tumour progression by impairing myeloid cell maturation
Marianna Papaspyridonos et al.
NATURE COMMUNICATIONS (2015)
SARS-Coronavirus Open Reading Frame-9b Suppresses Innate Immunity by Targeting Mitochondria and the MAVS/TRAF3/TRAF6 Signalosome
Chong-Shan Shi et al.
JOURNAL OF IMMUNOLOGY (2014)
Chronic but Not Acute Virus Infection Induces Sustained Expansion of Myeloid Suppressor Cell Numbers that Inhibit Viral-Specific T Cell Immunity
Brian A. Norris et al.
IMMUNITY (2013)
Myeloid-derived suppressor cells: the dark knight or the joker in viral infections?
Celeste Goh et al.
IMMUNOLOGICAL REVIEWS (2013)
Flagellin Induces Myeloid-Derived Suppressor Cells: Implications for Pseudomonas aeruginosa Infection in Cystic Fibrosis Lung Disease
Nikolaus Rieber et al.
JOURNAL OF IMMUNOLOGY (2013)
Chronic progressive HIV-1 infection is associated with elevated levels of myeloid-derived suppressor cells
Thomas Vollbrecht et al.
AIDS (2012)
Myeloid suppressor cells induced by hepatitis C virus suppress T-cell responses through the production of reactive oxygen species
Robert S. Tacke et al.
HEPATOLOGY (2012)
CXCR2: from bench to bedside
Anika Stadtmann et al.
FRONTIERS IN IMMUNOLOGY (2012)
Molecular mechanisms regulating myeloid-derived suppressor cell differentiation and function
Thomas Condamine et al.
TRENDS IN IMMUNOLOGY (2011)
Therapeutic targeting of myeloid-derived suppressor cells
Stefano Ugel et al.
CURRENT OPINION IN PHARMACOLOGY (2009)
Myeloid-derived suppressor cells as regulators of the immune system
Dmitry I. Gabrilovich et al.
NATURE REVIEWS IMMUNOLOGY (2009)
Myeloid-derived suppressor cells promote cross-tolerance in B-cell lymphoma by expanding regulatory T cells
Paolo Serafini et al.
CANCER RESEARCH (2008)
Share Paper
